FLT3 mutations have been shown to correlate with the very rare expression of CD34 in NPM1m AML [17,38]; indeed, in our entire NPM1m AML cohort, the only CD34+ case carried FLT3-ITD. This evidence concerns the gene CD34 and acute myeloid leukemia.